Drug Shortage Report for ACT METHYLPHENIDATE ER

Last updated on 2024-04-25 History
Report ID 223862
Drug Identification Number 02441934
Brand name ACT METHYLPHENIDATE ER
Common or Proper name METHYLPHENIDATE 18MG ER TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 18MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-03-28
Estimated end date 2024-05-10
Actual end date
Shortage status Actual shortage
Updated date 2024-04-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2024-04-25 French Compare
v8 2024-04-25 English Compare
v7 2024-04-11 French Compare
v6 2024-04-11 English Compare
v5 2024-04-05 French Compare
v4 2024-04-05 English Compare
v3 2024-03-29 English Compare
v2 2024-03-28 French Compare
v1 2024-03-28 English Compare

Showing 1 to 9 of 9